Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Alessia Romito 1 Article
Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer
Claudia Marchetti, Francesca De Felice, Anna Di Pinto, Alessia Romito, Angela Musella, Innocenza Palaia, Marco Monti, Vincenzo Tombolin, Ludovico Muzii, PierLuigi Benedetti Panici
Cancer Res Treat. 2018;50(3):768-776.   Published online July 19, 2017
DOI: https://doi.org/10.4143/crt.2017.141
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to develop nomograms for predicting the probability of overall survival (OS) and progression-free survival (PFS) in locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical surgery.
Materials and Methods
Nomograms to predict the 5-year OS rates and the 2-year PFS rates were constructed. Calibration plots were constructed, and concordance indices were calculated. Evaluated variableswere body mass index, age, tumor size, tumor histology, grading, lymphovascular space invasion, positive parametria, and positive lymph nodes.
Results
In total 245 patients with locally advanced cervical cancer who underwent neoadjuvant chemotherapy and radical surgery were included for the construction of the nomogram. The 5-year OS and PFS were 72.6% and 66%, respectively. Tumor size, grading, and parametria status affected the rate of OS, whereas tumor size and positive parametria were the main independent PFS prognostic factors.
Conclusion
We constructed a nomogram based on clinicopathological features in order to predict 2-year PFS and 5-year OS in locally advanced cervical cancer primarily treated with neoadjuvant chemotherapy followed by radical surgery. This tool might be particularly helpful for assisting in the follow-up of cervical cancer patients who have not undergone concurrent chemoradiotherapy.

Citations

Citations to this article as recorded by  
  • Plasma-based proteomic and metabolomic characterization of lung and lymph node metastases in cervical cancer patients
    Yue Feng, Zijian Sun, Huan Zhang, Zhao Wang, Lichao Wang, Hui Ye, Xiaojing Zhang, Zhuomin Yin, Juan Ni, Jingkui Tian, Hanmei Lou, Xiaojuan Lv, Wei Zhu
    Journal of Pharmaceutical and Biomedical Analysis.2025; 253: 116521.     CrossRef
  • Dose prediction for cervical cancer in radiotherapy based on the beam channel generative adversarial network
    Hui Xie, Tao Tan, Hua Zhang, Qing Li
    Heliyon.2024; 10(18): e37472.     CrossRef
  • Systematic review and meta-analysis of prediction models used in cervical cancer
    Ashish Kumar Jha, Sneha Mithun, Umeshkumar B. Sherkhane, Vinay Jaiswar, Biche Osong, Nilendu Purandare, Sadhana Kannan, Kumar Prabhash, Sudeep Gupta, Ben Vanneste, Venkatesh Rangarajan, Andre Dekker, Leonard Wee
    Artificial Intelligence in Medicine.2023; 139: 102549.     CrossRef
  • Development and validation of radiomic signature for predicting overall survival in advanced-stage cervical cancer
    Ashish Kumar Jha, Sneha Mithun, Umeshkumar B. Sherkhane, Vinay Jaiswar, Sneha Shah, Nilendu Purandare, Kumar Prabhash, Amita Maheshwari, Sudeep Gupta, Leonard Wee, V. Rangarajan, Andre Dekker
    Frontiers in Nuclear Medicine.2023;[Epub]     CrossRef
  • Advanced cervical stump cancer after laparoscopic subtotal hysterectomy: a case report of imaging, laparoscopic staging and treatment approach
    Dimitrios Andrikos, Argyrios Andrikos, Antoine Naem, Olga Ebertz, Rajesh Devassy, Rudy Leon De Wilde, Michael Khamou, Harald Krentel
    BMC Women's Health.2023;[Epub]     CrossRef
  • Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature
    Linlin Liu, Xianbo Deng, Shuang Guo, Shouhua Yang
    Diagnostic Pathology.2023;[Epub]     CrossRef
  • Influence of the Clinical Nursing Pathway on Nursing Outcomes and Complications of Cervical Carcinoma Patients Undergoing Chemotherapy via PICC
    Hongxia Tang, Li Gao, Yahui Li, Zhiqian Zhang
    Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
  • Current and future direction in treatment of HPV-related cervical disease
    Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour
    Journal of Molecular Medicine.2022; 100(6): 829.     CrossRef
  • Machine Learning of Dose-Volume Histogram Parameters Predicting Overall Survival in Patients with Cervical Cancer Treated with Definitive Radiotherapy
    Zhiyuan Xu, Li Yang, Qin Liu, Hao Yu, Longhua Chen, Claudia Marchetti
    Journal of Oncology.2022; 2022: 1.     CrossRef
  • Efficacy and safety of pembrolizumab on cervical cancer: A systematic review and single-arm meta-analysis
    Lin Qi, Ning Li, Aimin Lin, Xiuli Wang, Jianglin Cong
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
    Jing Liu, Guyu Tang, Qin Zhou, Weilu Kuang
    Radiation Oncology.2022;[Epub]     CrossRef
  • The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation
    Yi Sun, Gailing Li, Panpan Hai, Yuan Cao, Pin Han, Yuchen Liu, Jing Wen, Yuanpei Wang, Xiaoran Cheng, Fang Ren
    World Journal of Surgical Oncology.2022;[Epub]     CrossRef
  • Pembrolizumab for advanced cervical cancer: safety and efficacy
    Francesca De Felice, Elena Giudice, Giulia Bolomini, Maria Grazia Distefano, Giovanni Scambia, Anna Fagotti, Claudia Marchetti
    Expert Review of Anticancer Therapy.2021; 21(2): 221.     CrossRef
  • Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer
    Yifan Feng, Ye Wang, Yangqin Xie, Shuwei Wu, Yuyang Li, Min Li
    BMC Cancer.2021;[Epub]     CrossRef
  • Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)
    Setareh Akhavan, Abbas Alibakhshi, Mahdieh Parsapoor, Abbas Alipour, Elahe Rezayof
    BMC Cancer.2021;[Epub]     CrossRef
  • Macleayins A From Macleaya Promotes Cell Apoptosis Through Wnt/β-Catenin Signaling Pathway and Inhibits Proliferation, Migration, and Invasion in Cervical Cancer HeLa Cells
    Chunmei Sai, Wei Qin, Junyu Meng, Li-Na Gao, Lufen Huang, Zhen Zhang, Huannan Wang, Haixia Chen, Chaohua Yan
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
    Lele Zang, Qin Chen, Xiaozhen Zhang, Xiaohong Zhong, Jian Chen, Yi Fang, An Lin, Min Wang
    Cancer Management and Research.2021; Volume 13: 9391.     CrossRef
  • Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors
    Xiaomin Zheng, Weiqian Guo, Jiangning Dong, Liting Qian
    Magnetic Resonance Imaging.2020; 72: 159.     CrossRef
  • Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study
    Guilan Xie, Ruiqi Wang, Li Shang, Cuifang Qi, Liren Yang, Liyan Huang, Wenfang Yang, Mei Chun Chung
    BMC Cancer.2020;[Epub]     CrossRef
  • SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines
    Xing Chen, Dongsheng Xiong, Liya Ye, Huichun Yang, Shuangshuang Mei, Jinhong Wu, Shanshan Chen, Ruoran Mi
    Cancer Chemotherapy and Pharmacology.2019; 83(4): 603.     CrossRef
  • Systemic therapy in cervical cancer: 30 years in review
    Michalis Liontos, Anastasios Kyriazoglou, Ioannis Dimitriadis, Meletios-Athanasios Dimopoulos, Aristotelis Bamias
    Critical Reviews in Oncology/Hematology.2019; 137: 9.     CrossRef
  • Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis
    Meng Li, Mengyang Hu, Yuanjian Wang, Xingsheng Yang
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2019; 238: 1.     CrossRef
  • Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study
    Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong
    International Journal of Clinical Oncology.2019; 24(11): 1440.     CrossRef
  • Immune check-point in cervical cancer
    F. De Felice, C. Marchetti, I. Palaia, R. Ostuni, L. Muzii, V. Tombolini, P. Benedetti Panici
    Critical Reviews in Oncology/Hematology.2018; 129: 40.     CrossRef
  • 9,497 View
  • 396 Download
  • 30 Web of Science
  • 24 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP